Skip to main content
. 2010 Mar 24;72(1):44–50. doi: 10.1159/000292104

Fig. 2.

Fig. 2

Using qMSP, the FancB promoter was shown to be hypermethylated in HN-SCC patients: 14/45 (31.1%) of the tumor patients demonstrated hypermethylation of the FANCB locus compared to 1/16 (6.25%) of the normal patients (χ2; p < 0.05).